Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System
Conditions
Lung Neoplasm
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
navigation, bronchoscopy, lymphadenopathy
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Intervention
Name: LungPoint Virtual Bronchoscopic Navigation (computer-assisted image-guided bronchoscopic navigation)
Type: Device
Overall Status
Recruiting
Summary
To evaluate the role of the LungPoint VBN System in the bronchoscopic access to a target location.

The evaluation will explore:

- Ability of the system to guide a user to one or more target site(s)

- Ease of use of the system (assessment of the user interface)

- Incremental value brought by the use of the system to the successful completion of a case.
Detailed Description
Multi-center, prospective, single-arm study. The Study will take the form of a User Evaluation. The Evaluation will require the user to perform several standardized functions (e.g. peripheral lesion sampling, lymph node sampling). In addition, users will be asked about other potential techniques that fall within the intended use of the device.

The evaluation will be conducted in patients who are indicated for procedures that fall within the intended use of the device. Examples of such patients include:

- Patients who have been recommended for bronchoscopy for the purpose of obtaining a biopsy sample of a central or peripheral pulmonary lesion.

- Patients who have been recommended for bronchoscopy for the purpose of diagnosing mediastinal or hilar lymphadenopathy.

- Patients who have been recommended for bronchoscopy for the purpose of lung fiducial placement.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Subject has provided Informed Consent

- Subject is scheduled for bronchoscopy for the purpose of diagnosing: a central or peripheral pulmonary nodule or mass, infiltrative disease, mediastinal or hilar lymphadenopathy, or placing fiducial markers.

- Subject has a CT scan that is consistent with high-resolution specifications

Exclusion Criteria:

- Patients less than 18 years of age.

- Any patient that the Investigator feels is not appropriate for this study for any reason.
Location
Thoraxklinik
Heidelberg, Germany
Status: Recruiting
Contact: Felix Herth - Felix.Herth@thoraxklinik-heidelberg.de
Start Date
July 2009
Completion Date
March 2011
Sponsors
Broncus Technologies
Source
Broncus Technologies
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page